Photo via Semafor

Medical students should ‘learn the hard way,’ AI startup CEO says

Read the original at Semafor ↗
Cite

Angelo, J. (2026, November 17). Medical students should ‘learn the hard way,’ AI startup CEO says. Semafor. https://www.semafor.com/article/11/16/2026/medical-students-should-learn-the-hard-way-ai-startup-ceo-says

Dated from the outlet's own feed. Check the original for its byline.

Semafor · collected 2026-11-17 · by Jake Angelo

Quick Summary

Daniel Nadler, CEO of medical AI startup OpenEvidence, warned at Semafor’s Silicon Valley & The World conference that medical students should prioritize classical learning methods, including paper exams, to avoid cognitive offloading. OpenEvidence, valued at $15 billion, uses AI to condense complex medical information. Meanwhile, Benjamine Liu of Formation Bio highlighted the pharmaceutical industry's significant revenue potential from AI-driven drug development, noting that GLP-1 drugmakers outearned major AI companies last year.
Written by AI on 2026-11-17, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

At Semafor’s Silicon Valley & The World conference on Monday, OpenEvidence CEO Daniel Nadler advised medical students to "train classically, learn classically, learn the hard way," emphasizing the importance of doing paper exams to ensure they truly understand the material. Nadler, whose company has a $15 billion valuation, warned about the risk of cognitive offloading, where relying too heavily on AI can weaken cognitive performance. OpenEvidence uses AI to synthesize complex medical information from millions of medical papers, aiming to make medical knowledge more accessible to physicians. Formation Bio CEO Benjamine Liu, also speaking at the event, noted that AI systems can now perform the work of entire teams in the pharmaceutical industry.

Written for “Medical Students Warned About AI Reliance” on 2026-11-20, grounded in this article and the 0 other(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.

Story

Medical Students Warned About AI Reliance
Health · 1 article(s) covering the same event.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
11
sentences that state something as happening or true
Uncertain
0%
0 of 11 hedged ("reportedly", "may", "according to")
Leaning
withheld
no quote in the article backed the model's score
Publisher signals
64/100
Semafor's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-17 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Semafor · 1913 article(s) · 7 correction(s) detected
Running correction rate · 7 correction(s)

Who wrote this

Jake Angelo
23 article(s) here · 1 carrying a prediction
OpenAI is reportedly targeting a 2027 IPO; CEO Sam Altman said earlier this week at Semafor’s Silicon Valley & The World that OpenAI “will go public at some point,” even if there are “real downsides to being public,” including market volatility.
2026-11-19 · mixed framing · Anthropic makes record market debut
“It would become one of the biggest failures of our time if we don’t, as a society,” Li said, “if we don’t resource [the] public sector in a serious way.”
He would advise students to “train classically, learn classically, learn the hard way, do paper exams, do paper tests, make sure you actually know it,” he told Semafor’s Mohammed Sergie.
“He would run the company like as if he would run out of business in the next 30 days,” he recalled.
Sacks is a staunch proponent of the AI buildout, and has argued that any guardrails on the technology’s development would hamstring the US in its competition with China.
2026-11-16 · assertive framing · Sacks criticizes rush to judgment on ex-Nvidia CEO
Sacks is a staunch proponent of the AI buildout, and has argued that any guardrails on the technology’s development would hamstring the US in its competition with China.
2026-11-16 · assertive framing · Sacks criticizes rush to judgment on ex-Nvidia CEO
The ChatGPT maker will award 50,000 new grants for researchers on a first-come, first-served basis, allowing recipients to grant access to up to two collaborators each.
It was unclear when flights would resume, or how long the order would remain in effect, but shares in airlines dropped.
2026-11-13 · assertive framing · FAA issues rare nationwide ground stop
Silicon Valley’s bet that billions of agents will be out ordering food, booking travel, and filling up their humans’ shopping carts is running into an (admittedly early) reality check.
2026-11-10 · mixed framing · Agentic commerce is slow to catch on
The economy’s resilience adds to evidence that the US Federal Reserve will hike interest rates at its December meeting, allowing the central bank to focus on tackling elevated inflation stemming from the Iran war: Odds of a rate hike jumped 12 percentage points following the release, according to CME Fedwatch.
Also by Jake Angelo
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 23 articles by Jake Angelo →

Topics

Formation Bio OpenAI OpenEvidence Semafor Silicon Valley & The World

Subjects

Nadler PERSON · 2× Semafor ORG · 2× Anthropic ORG · 1× Benjamine Liu PERSON · 1× Daniel Nadler PERSON · 1× Formation Bio ORG · 1× Mohammed Sergie PERSON · 1× OpenAI ORG · 1× OpenEvidence ORG · 1× Silicon Valley & The World ORG · 1×

Narrative

Benjamine Liu, the CEO of Formation Bio, which uses AI to accelerate drug development, also noted onstage on Monday that in the pharmaceutical industry “AI systems can begin to now do the work of entire teams.”
framing: assertive · carried by 1 article(s) · first seen 2026-11-17
He would advise students to “train classically, learn classically, learn the hard way, do paper exams, do paper tests, make sure you actually know it,” he told Semafor’s Mohammed Sergie.

Claims (11 extracted, 0 hedged)

The CEO of a major medical AI startup said on Monday that medical students should do paper exams and master the material, even if they also use AI. asserted
they → say → AI
“The risk of cognitive offloading is really, really acute,” OpenEvidence CEO Daniel Nadler said at Semafor’s Silicon Valley & The World. asserted
Nadler → say → Valley
He would advise students to “train classically, learn classically, learn the hard way, do paper exams, do paper tests, make sure you actually know it,” he told Semafor’s Mohammed Sergie. asserted
he → advise → Sergie
Nadler’s company aims to cover a niche within the medical business, synthesizing complex medical information with AI trained on millions of medical papers. asserted
company → aim → papers
The startup has hit a $15 billion valuation on the promise that AI can condense the complexities of the medical field into information palatable to physicians. asserted
AI → hit → physicians
Early studies have found that deferring work to AI can weaken neural networks, leading to lower cognitive performance. asserted
deferring → find → performance
Nadler says the concern is especially pressing for younger generations, those who have grown up in academic environments with access to AI. asserted
who → say → AI
He noted that all of his company’s engineers use “dozens and dozens of AI buddies.” asserted
all → note → buddies
Benjamine Liu, the CEO of Formation Bio, which uses AI to accelerate drug development, also noted onstage on Monday that in the pharmaceutical industry “AI systems can begin to now do the work of entire teams.” asserted
systems → use → teams
Noting that the GLP-1 drugmakers “did more revenue than OpenAI and Anthropic combined last year,” he told Sergie that “some people underestimate how big pharma is.” asserted
pharma → note → Sergie
“We’re early innings in these things that help you live longer and healthier — and in an area that our industry sometimes misses,” Liu said. asserted
Liu → ’re → that
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support